I just saw a news article that Hong Kong-listed company Huajian Medical will be allocating to crypto assets. This company is conducting its crypto asset allocation through the compliance-first Hashkey @HashKeyExchange! ➡️ They plan to reserve 880 million HKD worth of ETH as a core strategic reserve, which is about 110 million USD. This is the first publicly listed "big tech" company in Hong Kong to allocate to crypto assets. But it definitely won't be the last. In the future, more and more Hong Kong-listed companies will start buying crypto assets, striving to become Hong Kong's "MicroStrategy." As I mentioned a few days ago, Hashkey is a major player in Hong Kong's crypto compliance, and I personally believe it will also help its business expand geometrically. Just some data: Currently, there are over 2,600 listed companies in Hong Kong. Even if just one-tenth of them allocate to crypto assets, it will be a significant force for the "climb" of the crypto market and the expansion of the Hong Kong crypto market. To extend a bit: I personally think there is a real chance that a local version of "MicroStrategy" will emerge in Hong Kong stocks, and I will continue to pay attention and participate. Looking forward to a wave: Hong Kong local companies buying crypto assets ➡️ Stock prices rise ➡️ Other Hong Kong companies follow suit ➡️ Crypto market/related companies take off ➡️ More companies join.
HashKey Exchange
HashKey Exchange11.8. klo 18.17
💡 Public companies are accelerating their layout in digital assets. In Asia, more and more enterprises are choosing HashKey Exchange as their preferred strategic partner to advance asset allocation upgrades. Today, HashKey Exchange × IVD Huajian Medical officially joins hands— 💰 Huajian Medical has initially invested HKD 149 million in Ethereum $ETH. It is reported that since the first investment on August 5, it has recorded a floating profit of over HKD 24.48 million. 🔐 Together, we are building an "Ethereum Vault" to promote the development of enterprise-level digital assets and the Web3 medical ecosystem. This material is for reference only. It does not constitute, nor should it be interpreted as, any form of solicitation, offer, or recommendation of any product or service. It does not constitute investment, tax, or legal advice.
29,27K